Darmendra Ramcharran, PhD, MPH

Sr Director, Safety Innovation & Analtyics
GSK

Poster(s):

• (A-237) Age and multimodal safety assessments: limitations of spontaneous reports data and the importance of advancing age-based risk stratification capabilities in real world data
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-201) An evidence base to support the establishment of a fit-for-purpose quality management system for secondary data pharmacoepidemiological studies
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-238) Enhancing Post-marketing Quantitative Signal Detection at GSK: A Comprehensive Review
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-240) Enhancing The Meaningfulness of Qualitative Adverse Event Report Reviews Through Incorporation of Quantitative and Qualitative Aspects of Causality Assessment
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-239) Risk-Based Stratification of Pharmacovigilance Data for a Differentiated Approach to Follow-Up
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-267) Using Machine Learning to Predict Classification of Causal and Non-causal Pharmacovigilance Cases
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET